Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Dermapharm Holding SE, DE000A2GS5D8

Dermapharm Holding SE, DE000A2GS5D8

12.02.2021 - 13:13:52

Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million - in sales in 2021

cometis AG Claudius Krause Phone: +49 (0)611 - 205855-28 Fax: +49 (0)611 - 205855-66 e-Mail: ir@dermapharm.com

12.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Dermapharm Holding SE Lil-Dagover-Ring 7 82031 Gr?nwald

Germany Phone: +49 (0)89 64 86-0 E-mail: ir@dermapharm.com Internet: ir.dermapharm.de ISIN: DE000A2GS5D8 WKN: A2GS5D Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange EQS News ID: 1167967 ? End of News DGAP News Service


@ dgap.de